{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:06:50Z","timestamp":1788498410554,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/ejhg.2011.38","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T11:21:29Z","timestamp":1300274489000},"page":"789-795","source":"Crossref","is-referenced-by-count":12,"title":["Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence"],"prefix":"10.1038","volume":"19","author":[{"given":"Elaine A","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh M","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kingswood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Corderio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Duarte","family":"Medeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Mark","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"key":"BFejhg201138_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993; 75: 1305\u20131315.","journal-title":"Cell"},{"key":"BFejhg201138_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C et al: Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 277: 805\u2013808.","journal-title":"Science"},{"key":"BFejhg201138_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1086\/302381","volume":"64","author":"AC Jones","year":"1999","unstructured":"Jones AC, Shyamsundar MM, Thomas MW et al: Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999; 64: 1305\u20131315.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201138_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","volume":"68","author":"SL Dabora","year":"2001","unstructured":"Dabora SL, Jozwiak S, Franz DN et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68: 64\u201380.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201138_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak O, Nellist M, Goedbloed M et al: Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005; 13: 731\u2013741.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201138_CR6","unstructured":"Sue Povey and Rosemary Ekong (2005-2009). Tuberous sclerosis database. LOVD v.2.0, \n                    http:\/\/chromium.liacs.nl\/LOVD2\/TSC\/home.php?select_db=TSC2\n                    \n                  ."},{"key":"BFejhg201138_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<408::AID-HUMU7>3.0.CO;2-P","volume":"12","author":"RL Beauchamp","year":"1998","unstructured":"Beauchamp RL, Banwell A, McNamara P et al: Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis. Hum Mutat 1998; 12: 408\u2013416.","journal-title":"Hum Mutat"},{"key":"BFejhg201138_CR8","unstructured":"Bell J, Bodmer D, Sistermans E, Ramsden S : Practice guidelines for the Interpretation and Reporting of Unclassified Variants (UVs) in Clinical Molecular Genetics, 2007, \n                    www.cmgs.org\/BPGs\/pdfs%20current%20bpgs\/UV%20GUIDELINES%20ratified.pdf\n                    \n                  ."},{"key":"BFejhg201138_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2350-10-88","volume":"10","author":"M Mozaffari","year":"2009","unstructured":"Mozaffari M, Hoogeveen-Westerveld M, Kwiatkowski D et al: Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex. BMC Med Genet 2009; 10: 88.","journal-title":"BMC Med Genet"},{"key":"BFejhg201138_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ejhg.2008.170","volume":"17","author":"M Nellist","year":"2009","unstructured":"Nellist M, van den Heuvel D, Schluep D et al: Missense mutations to the TSC1 gene cause tuberous sclerosis complex. Eur J Hum Genet 2009; 17: 319\u2013328.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201138_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ejhg.2008.184","volume":"17","author":"R Coevoets","year":"2009","unstructured":"Coevoets R, Arican S, Hoogeveen-Westerveld M et al: A reliable cell-based assay for testing unclassified TSC2 gene variants. Eur J Hum Genet 2009; 17: 301\u2013310.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg201138_CR12","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J : Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 2002; 99: 13571\u201313576.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg201138_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/ncb999","volume":"5","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Gao X, Saucedo LJ, Ru B, Edgar BA, Pan D : Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat Cell Biol 2003; 5: 578\u2013581.","journal-title":"Nat Cell Biol"},{"key":"BFejhg201138_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","volume":"11","author":"A Garami","year":"2003","unstructured":"Garami A, Zwartkruis FJ, Nobukuni T et al: Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11: 1457\u20131466.","journal-title":"Mol Cell"},{"key":"BFejhg201138_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL : Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17: 1829\u20131834.","journal-title":"Genes Dev"},{"key":"BFejhg201138_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J : Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 2003; 13: 1259\u20131268.","journal-title":"Curr Biol"},{"key":"BFejhg201138_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s004390000316","volume":"106","author":"AC Jones","year":"2000","unstructured":"Jones AC, Sampson JR, Hoogendoorn B Cohen D, Cheadle JP : Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Hum Genet 2000; 106: 663\u2013668.","journal-title":"Hum Genet"},{"key":"BFejhg201138_CR18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0960-9822(02)00762-5","volume":"12","author":"SS Schalm","year":"2002","unstructured":"Schalm SS, Blenis J : Identification of a conserved motif required for mTOR signalling. Curr Biol 2002; 12: 632\u2013639.","journal-title":"Curr Biol"},{"key":"BFejhg201138_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cellsig.2009.02.024","volume":"21","author":"EA Dunlop","year":"2009","unstructured":"Dunlop EA, Dodd KM, Seymour LA, Tee AR : Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition. Cell Signal 2009; 21: 1073\u20131084.","journal-title":"Cell Signal"},{"key":"BFejhg201138_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/088307389801301206","volume":"13","author":"ES Roach","year":"1998","unstructured":"Roach ES, Gomez MR, Northrup H : Tuberous Sclerosis Complex Consensus Conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13: 624\u2013628.","journal-title":"J Child Neurol"},{"key":"BFejhg201138_CR21","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M611782200","volume":"282","author":"SC Land","year":"2007","unstructured":"Land SC, Tee AR : Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007; 282: 20534\u201320543.","journal-title":"J Biol Chem"},{"key":"BFejhg201138_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1083\/jcb.200507119","volume":"173","author":"SL Cai","year":"2006","unstructured":"Cai SL, Tee AR, Short JD et al: Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J Cell Biol 2006; 173: 279\u2013289.","journal-title":"J Cell Biol"},{"key":"BFejhg201138_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0960-9822(03)00329-4","volume":"13","author":"SS Schalm","year":"2003","unstructured":"Schalm SS, Fingar DC, Sabatini DM, Blenis J : TOS Motif-mediated raptor binding regulates 4E-bp1multisite phosphorylation and function. Curr Biol 2003; 13: 797\u2013806.","journal-title":"Curr Biol"},{"key":"BFejhg201138_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","volume":"110","author":"K Hara","year":"2002","unstructured":"Hara K, Maruki Y, Long X et al: Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110: 177\u2013189.","journal-title":"Cell"},{"key":"BFejhg201138_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.1167363","volume":"322","author":"RG Cotton","year":"2008","unstructured":"Cotton RG, Auerbach AD, Axton M et al: The Human Variome Project. Science 2008; 322: 861\u2013862.","journal-title":"Science"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201138","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:04:49Z","timestamp":1684429489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFejhg201138"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2011.38","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]}}}